Hospital
Frio Hospital Association
Frio Hospital Association was paid $2.23M by Medicaid between Sep 2019 and Nov 2024, across 45 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoFRIO HOSPITAL ASSOCIATION
PEARSALL, TX 78061
PEARSALL, TX 78061
33aNPI1447574819assigned 03/15/2010
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$2.23M
24GClaims25,256
24DCodes billed45
24AFirst – last monthSep 2019 – Nov 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Texas
Rank by total paid#2 of 6
Median peer was paid$983K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 71 | $0.00 | |
| 2020 | 395 | $37K | |
| 2021 | 5,020 | $288K | |
| 2022 | 8,185 | $541K | |
| 2023 | 8,178 | $926K | |
| 2024incomplete | 3,407 | $441K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 2,237 | 2,099 | $830K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 3,537 | 3,344 | $465K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 643 | 588 | $397K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 14% | 557 | 526 | $319K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 662 | 614 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 1,016 | 957 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,173 | 714 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,135 | 1,045 | $23K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 126 | 25 | $18K |
| 80053 | Comprehensive metabolic panel | <1% | 2,422 | 2,155 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 492 | 416 | $13K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 650 | 587 | $12K |
33 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 105 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,373 | $11K |
| 87428 | <1% | 87 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 420 | $4K |
| 76376 | <1% | 260 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 120 | $2K |
| 81001 | <1% | 665 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 42 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,893 | $2K |
| A9150 | Non-prescription drugs | <1% | 397 | $2K |
| 83880 | <1% | 108 | $762.53 | |
| 80061 | Lipid panel | <1% | 41 | $698.75 |
| 94760 | <1% | 154 | $617.96 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 41 | $512.29 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 25 | $479.12 |
| 81003 | <1% | 353 | $410.77 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 187 | $312.83 |
| 84439 | <1% | 32 | $304.35 | |
| 80305 | <1% | 14 | $227.81 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 14 | $208.64 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 64 | $206.91 |
| 84484 | <1% | 377 | $159.09 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $157.12 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 50 | $119.27 |
| 82550 | <1% | 199 | $63.74 | |
| 83735 | <1% | 14 | $57.60 | |
| 82553 | <1% | 144 | $49.84 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 55 | $20.86 |
| A4649 | Surgical supply; miscellaneous | <1% | 68 | $16.85 |
| 85610 | <1% | 19 | $8.24 | |
| 85730 | <1% | 12 | $5.77 | |
| J3490 | Unclassified drugs | 0% | 175 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 82 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, MICHAEL (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Thompson Bros Investments LLC | Ball, LA | $16.57M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.